Fulcrum Therapeutics Inc. (FULC) Earnings
|
Expand Research on FULC
| Next EPS Date | 10/29/26 | EPS Growth Rate | +61.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +1.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/26  |
Q326 | N/A | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/31/26 |
Q226 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/24/26 |
Q226 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/17/26 |
Q226 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/5/26 |
Q226 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 4/27/26 | Q126 | -$0.25 | -$0.30 | +$0.05 | N/A | N/A | N/A |  | | Details | |
| 2/24/26 |
Q425 | N/A | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 10/29/25 | Q325 | -$0.31 | -$0.29 | -$0.02 | N/A | N/A | N/A | | | Details |
